Comparison of clinical and MRD based risk groups in the study by Van Dongen and colleagues10
| Clinical risk assessment | MRD based risk assessment | ||||
|---|---|---|---|---|---|
| Risk group | % Of patients | 3 year RFS (%) | Risk group | % Of patients | 3 year RFS (%) |
| MRD, minimal residual disease; RFS, recurrence free survival. | |||||
| Standard | 26 | 87 | Low | 42.5 | 98 |
| Medium | 64.5 | 80 | Intermediate | 42.5 | 77 |
| High | 9.5 | 30 | High | 15 | 25 |